Lauren R. Buckley
Lauren Randall Buckley, Group President of Health & Reimbursement Policy, has spent her career representing innovative healthcare technology companies before the Administration and Congress on cutting-edge federal regulatory, policy, and legislative issues. Her past experience as a policy advisor and lobbyist in corporate and client-service settings provide her a unique perspective for providing forward-thinking strategic advice and translating complex policy challenges into potential future opportunities.
Ms. Buckley’s practice focuses primarily on providing strategic advice on health policy and reimbursement matters, as well as representing clients before the Centers for Medicare and Medicaid Services (CMS) and other key policy stakeholders. She regularly advises biopharmaceutical and cell and gene therapy companies of all sizes on health policy matters relating to federal healthcare programs, such as Medicare Part B, Medicare Part D, 340B, and Medicaid. She possesses extensive experience relating to federal healthcare program payment systems and fee schedules, as well as on policy issues pertaining to drug price reporting methodologies. Ms. Buckley assists pre-commercial companies in developing strategic health policy objectives and provides education relating to critical aspects of coverage, coding, and payment parameters.
Ms. Buckley has successfully represented companies in obtaining HCPCS, CPT, ICD-10-PCS, and ICD-10-CM diagnosis codes, as well as Medicare Part B Transitional Pass-through Payment Status under the Hospital Outpatient Prospective Payment System. She also assists companies in developing strategies for mitigating coverage challenges, as well as technical coding and payment policy issues. She regularly advocates for client priorities through rulemaking comments, proposals, and engagements with CMS.
Prior to joining Kimbell & Associates, Ms. Buckley led the U.S. federal health policy portfolio and served as a lobbyist for MedImmune, a biotechnology company that is now part of AstraZeneca. Before joining MedImmune, Ms. Buckley practiced law as a senior associate in the Healthcare Regulatory practice group at Sidley Austin LLP. She began her career as an associate in the Washington, DC office of DLA Piper.
Ms. Buckley holds a Juris Doctor degree from the Washington College of Law at American University and a Bachelor of Science degree in Marketing and minor in Political Science from Penn State University, Schreyer Honors College.
Ms. Buckley’s practice focuses primarily on providing strategic advice on health policy and reimbursement matters, as well as representing clients before the Centers for Medicare and Medicaid Services (CMS) and other key policy stakeholders. She regularly advises biopharmaceutical and cell and gene therapy companies of all sizes on health policy matters relating to federal healthcare programs, such as Medicare Part B, Medicare Part D, 340B, and Medicaid. She possesses extensive experience relating to federal healthcare program payment systems and fee schedules, as well as on policy issues pertaining to drug price reporting methodologies. Ms. Buckley assists pre-commercial companies in developing strategic health policy objectives and provides education relating to critical aspects of coverage, coding, and payment parameters.
Ms. Buckley has successfully represented companies in obtaining HCPCS, CPT, ICD-10-PCS, and ICD-10-CM diagnosis codes, as well as Medicare Part B Transitional Pass-through Payment Status under the Hospital Outpatient Prospective Payment System. She also assists companies in developing strategies for mitigating coverage challenges, as well as technical coding and payment policy issues. She regularly advocates for client priorities through rulemaking comments, proposals, and engagements with CMS.
Prior to joining Kimbell & Associates, Ms. Buckley led the U.S. federal health policy portfolio and served as a lobbyist for MedImmune, a biotechnology company that is now part of AstraZeneca. Before joining MedImmune, Ms. Buckley practiced law as a senior associate in the Healthcare Regulatory practice group at Sidley Austin LLP. She began her career as an associate in the Washington, DC office of DLA Piper.
Ms. Buckley holds a Juris Doctor degree from the Washington College of Law at American University and a Bachelor of Science degree in Marketing and minor in Political Science from Penn State University, Schreyer Honors College.
